Pfizer (PFE) has seen its stock price move gradually higher over the past week, rising nearly 15% in that period. Investors ...

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 5.9% in the afternoon session after the company reached an ...

Pharma stocks have been under pressure from the administration in 2025.

Pfizer (PFE) shares may have broken out. This means a large amount of supply has come off the market. This is bullish.

What Happened? Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 7.2% in the afternoon session after the ...

Pfizer PFE announced a definitive agreement to acquire obesity drug developer, Metsera MTSR, to re-enter the lucrative ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $29.25, a high estimate of $33.00, and a low estimate of $26.00. Marking an ...

This drop brings the stock's year-to-date decline to almost 45%. A key question now is how MRNA's performance compares to ...

Pfizer's strong pipeline of drugs and its fortress balance sheet make it an attractive investment at cheap valuation ...

Pfizer Inc. (NYSE:PFE) is one of the best large cap value stocks to buy now. On September 23, Bank of America Securities ...